Bluefin Capital Management, LLC Pfizer Inc Call Options Transaction History

Bluefin Capital Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 16, 2024	BUY	$26.13 - $33.94 $7.06 Million - $9.17 Million	270,100 New	270,100 $7.78 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $525,120 - $641,040	-12,000 Reduced 10.56%	101,600 $9,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $3.41 Million - $4.04 Million	-73,300 Reduced 39.22%	113,600 $130,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $16.3 Million - $20.1 Million	-355,200 Reduced 65.52%	186,900 $267,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $16.9 Million - $25 Million	408,500 Added 305.76%	542,100 $4.47 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $4.85 Million - $6.23 Million	123,600 Added 1236.0%	133,600 $25,000
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $359,099 - $406,800	-10,000 Reduced 50.0%	10,000 $0
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $669,800 - $755,400	20,000 New	20,000 $6,000

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.